Sanlam Life Insurance currently holds 28.7% in ACT Healthcare Assets, which in turn holds AfroCentric’s businesses, including Medscheme and AfroCentric’s pharmacy businesses – Pharmacy Direct, medicinal wholesaler Curasana and Activo Health.
The AfroCentric transaction will see Sanlam transfer its shareholding in ACT Healthcare Assets to AfroCentric in exchange for a 28.7% controlling stake in AfroCentric. Sanlam group CEO Paul Hanratty says Afrocentric will be an “attractive addition to Sanlam’s stable of offerings”, being a diversified and integrated healthcare provider that provides services to 3.8 million members. The deal is subject to approvals from the Competition Tribunal and Takeover Regulation Panel.
All signs point to further growth as Sanlam’s discretionary capital increased from R2.9-billion at the end of 2021 to R6.6-billion by the end of June this year.